Style | Citing Format |
---|---|
MLA | Mirzaei M, et al.. "Novel Nanosized Gd3+-Algd-G2 -C595: In Vivo Dual Selective Muc-1 Positive Tumor Molecular Mr Imaging and Therapeutic Agent." Journal of Nanomedicine and Nanotechnology, vol. 3, no. 7, 2012, pp. 4-. |
APA | Mirzaei M, Mohagheghi M, Shahbazigahrouei D, Khatami A (2012). Novel Nanosized Gd3+-Algd-G2 -C595: In Vivo Dual Selective Muc-1 Positive Tumor Molecular Mr Imaging and Therapeutic Agent. Journal of Nanomedicine and Nanotechnology, 3(7), 4-. |
Chicago | Mirzaei M, Mohagheghi M, Shahbazigahrouei D, Khatami A. "Novel Nanosized Gd3+-Algd-G2 -C595: In Vivo Dual Selective Muc-1 Positive Tumor Molecular Mr Imaging and Therapeutic Agent." Journal of Nanomedicine and Nanotechnology 3, no. 7 (2012): 4-. |
Harvard | Mirzaei M et al. (2012) 'Novel Nanosized Gd3+-Algd-G2 -C595: In Vivo Dual Selective Muc-1 Positive Tumor Molecular Mr Imaging and Therapeutic Agent', Journal of Nanomedicine and Nanotechnology, 3(7), pp. 4-. |
Vancouver | Mirzaei M, Mohagheghi M, Shahbazigahrouei D, Khatami A. Novel Nanosized Gd3+-Algd-G2 -C595: In Vivo Dual Selective Muc-1 Positive Tumor Molecular Mr Imaging and Therapeutic Agent. Journal of Nanomedicine and Nanotechnology. 2012;3(7):4-. |
BibTex | @article{ author = {Mirzaei M and Mohagheghi M and Shahbazigahrouei D and Khatami A}, title = {Novel Nanosized Gd3+-Algd-G2 -C595: In Vivo Dual Selective Muc-1 Positive Tumor Molecular Mr Imaging and Therapeutic Agent}, journal = {Journal of Nanomedicine and Nanotechnology}, volume = {3}, number = {7}, pages = {4-}, year = {2012} } |
RIS | TY - JOUR AU - Mirzaei M AU - Mohagheghi M AU - Shahbazigahrouei D AU - Khatami A TI - Novel Nanosized Gd3+-Algd-G2 -C595: In Vivo Dual Selective Muc-1 Positive Tumor Molecular Mr Imaging and Therapeutic Agent JO - Journal of Nanomedicine and Nanotechnology VL - 3 IS - 7 SP - 4 EP - PY - 2012 ER - |